| Literature DB >> 35160020 |
María Carratalá-Tejada1, Alicia Cuesta-Gómez1, Rosa Ortiz-Gutiérrez2, Francisco Molina-Rueda1, Laura Luna-Oliva1, Juan Carlos Miangolarra-Page1,3.
Abstract
This study evaluates the effects of a rehabilitation program based on reflex locomotion therapy (RLT) on balance, gait, and fatigue in patients with multiple sclerosis (MS). Twenty-three patients diagnosed with MS participated in this study. Reversal design was carried out. The assessment tools included the Berg Balance Scale (BBS), the Performance Oriented Mobility Assessment (POMA), the Fatigue Severity Scale (FSS) and the instrumental analysis of the gait recorded by Vicon Motion System®. We analyzed spatio-temporal parameters and kinematic variables of the hip, knee, and ankle joints. Additionally, the Client Satisfaction Questionnaire (CSQ-8) was administrated. We did find a significant improvement in balance and gait tools after the RLT period. Regarding instrumental analysis, the statistical analysis of spatio-temporal parameters showed a significant improvement in stride length, double support, and velocity after the RLT period. Concerning kinematic parameters, the analysis showed improvements in hip and knee range of motion (ROM) after RLT period. RLT could improve gait and balance in patients with MS. The patients reported a high level of satisfaction with the therapy received.Entities:
Keywords: Vojta therapy; gait analysis; kinematics; kinetics; multiple sclerosis; reflex locomotion therapy
Year: 2022 PMID: 35160020 PMCID: PMC8836377 DOI: 10.3390/jcm11030567
Source DB: PubMed Journal: J Clin Med ISSN: 2077-0383 Impact factor: 4.241
Figure 1Experimental procedure.
Figure 2Application of reflex locomotion therapy (RLT). Reflex crawling: (a) original reflex crawling and (b) first position; reflex turning: (c) first and (d) second phase of turning.
Characteristics of the sample.
| Variable | Subjects | ||
|---|---|---|---|
| Age (years) * | 44.39 (7.37) | ||
| Sex | ♀ 73.91% ( | ♂ 26.08% ( | |
| Most affected side | Right | Left | |
| Years since diagnosis * | 14.39 (5.85) | ||
| Type of MS | RRMS 56.52% ( | SPMS 21.73% ( | PPMS 21.73% ( |
* Data expressed as mean (standard deviation). MS. Multiple Sclerosis. EMRR. Relapsing remitting multiple sclerosis. SPMS. Secondary progressive multiple sclerosis. PPMS. Primary progressive multiple sclerosis. ♀: woman. ♂: men.
Clinical variables: tests for balance, gait and fatigue.
| Mean (SD) | Second vs. Baseline Measurement | Third vs. Second Measurement | Fourth vs. Third Measurement | ||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Baseline | Second Measure | Third Measure | Fourth Measure | DM |
| CI 95% | DM |
| CI 95% | DM |
| CI 95% | |
| Berg Balance Scale | 46.21 ± 7.24 | 46.13 ± 7.17 | 49.65 ± 5.56 | 49.08 ± 6.26 | −0.09 | 1.000 | −1.94 to 1.76 | 3.52 | <0.001 * | 1.67 to 5.37 | −0.57 | 1.000 | −2.41 to 1.28 |
| Balance section of POMA | 11.56 ± 2.51 | 11.47 ± 2.71 | 13.34 ± 2.08 | 13.13 ± 1.79 | −0.09 | 1.000 | −0.97 to 0.79 | 1.87 | <0.001 * | 0.99 to 2.75 | −0.22 | 1.000 | −1.10 to 0.66 |
| Gait section of POMA | 8.43 ± 2.33 | 8.39 ± 2.38 | 9.73 ± 1.98 | 9.30 ± 2.22 | −0.04 | 1.000 | −0.58 to 0.50 | 1.35 | <0.001 * | 0.81 to 1.89 | −0.43 | 0.190 | −0.97 to 0.10 |
| Fatigue severity scale | 49.52 ± 10.99 | 49.39 ± 11.69 | 47.47 ± 10.08 | 47.26 ± 11.33 | −0.13 | 1.000 | −3.92 to 3.66 | −1.91 | 1.000 | −5.70 to 1.88 | −0.22 | 1.000 | −4.01 to 3.57 |
* p < 0.05 using ANOVA of repeated measures (post hoc Bonferroni Adjustment). SD, standard deviation. Baseline measurement is before the first intervention period A, the second measurement is after the first intervention period A and before the intervention period B, the third measurement is after the intervention period B and before the second intervention period A, and the fourth measurement is after the second intervention period A.
Figure 3Change (mean) in balance, gait and fatigue parameters during the experimental protocol. * p < 0.05 using ANOVA of repeated measures between the third and second measurements.
The statistical analysis of spatio-temporal parameters.
| Mean (SD) | Second vs. Baseline Measurement | Third vs. Second Measurement | Fourth vs. Third Measurement | ||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Baseline | Second Measure | Third Measure | Fourth Measure | DM |
| CI 95% | DM |
| CI 95% | DM |
| CI 95% | |
| Stride length | 0.98 ± 0.23 | 0.98 ± 0.24 | 1.09 ± 0.23 | 1.08 ± 0.21 | −0.0012 | 1.000 | −0.07 to 0.06 | 0.113 | <0.01 * | 0.05 to 0.18 | −0.01 | 1.00 | −0.08 to 0.05 |
| Single support | 0.47 ± 0.08 | 0.47 ± 0.08 | 0.46 ± 0.10 | 0.48 ± 0.11 | −0.0002 | 1.000 | −0.03 to 0.03 | −0.004 | 1.00 | −0.03 to 0.02 | 0.02 | 0.70 | −0.01 to 0.04 |
| Double support | 0.43 ± 0.26 | 0.43 ± 0.26 | 0.37 ± 0.21 | 0.41 ± 0.32 | −0.0070 | 1.000 | −0.07 to 0.05 | −0.059 | 0.047 * | −0.12 to −0.0004 | 0.04 | 0.30 | −0.02 to 0.10 |
| Velocity | 0.77 ± 0.24 | 0.76 ± 0.26 | 0.88 ± 0.29 | 0.86 ± 0.28 | −0.0049 | 1.000 | −0.08 to 0.07 | 0.114 | 0.001 * | 0.04 to 0.19 | −0.02 | 1.00 | −0.09 to 0.06 |
* p < 0.05 using ANOVA of repeated measures (post hoc Bonferroni Adjustment). SD, standard deviation. Baseline measurement is before the first intervention period A, the second measurement is after the first intervention period A and before the intervention period B, the third measurement is after the intervention period B and before the second intervention period A, and the fourth measurement is after the second intervention period A.
The statistical analysis of kinematic parameters.
| Kinematic (Degrees) | Mean (SD) | Second vs. Baseline Measurement | Third vs. Second Measurement | Fourth vs. Third Measurement | |||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Baseline | Second Measure | Third Measure | Fourth Measure | DM |
| CI 95% | DM |
| CI 95% | DM |
| CI 95% | |
| Hip ROM | 40.18 ± 8.21 | 40.25 ± 8.28 | 42.92 ± 6.69 | 43.20 ± 7.28 | 0.07 | 1.00 | −2.03 to 2.18 | 2.66 | 0.006 * | 0.56 to 4.77 | 0.28 | 1.00 | −1.82 to 2.39 |
| Hip angle at IC | 30.75 ± 8.93 | 30.55 ± 8.89 | 32.07 ± 8.10 | 31.98 ± 8.38 | −0.20 | 1.00 | −2.54 to 2.14 | 1.52 | 0.47 | −0.83 to 3.86 | −0.24 | 1.00 | −2.601 to 2.13 |
| Peak hip extension stance period | −7.13 ± 9.69 | −7.48 ± 10.04 | −8.44 ± 8.97 | −8.75 ± 7.56 | −0.35 | 1.00 | −3.16 to 2.46 | −0.95 | 1.00 | −3.76 to 1.86 | 0.60 | 1.00 | −2.35 to 3.56 |
| Peak hip flexion swing period | 32.70 ± 9.12 | 32.42 ± 9.16 | 34.08 ± 8.45 | 34.18 ± 8.30 | −0.28 | 1.00 | −3.10 to 2.53 | 1.67 | 0.67 | −1.15 to 4.48 | −0.06 | 1.00 | −2.91 to 2.78 |
| Knee ROM | 49.80 ± 4.18 | 49.74 ± 14.08 | 52.75 ± 12.18 | 51.79 ± 11.50 | −0.06 | 1.00 | −3.47 to 3.36 | 3.01 | 0.045 * | −0.40 to 6.43 | −0.97 | 1.00 | −4.38 to 2.45 |
| Knee angle at IC | 6.53 ± 8.32 | 6.35 ± 8.43 | 3.94 ± 7.69 | 4.78 ± 7.09 | −0.19 | 1.00 | −2.65 to 2.28 | −2.23 | 0.097 | −4.70 to 0.23 | 0.67 | 1.00 | −1.80 to 3.14 |
| Peak knee flexion swing period | 50.04 ± 3.21 | 49.77 ± 13.08 | 49.66 ± 11.95 | 49.38 ± 11.32 | −0.27 | 1.00 | −4.20 to 3.65 | −0.11 | 1.00 | −4.03 to 3.82 | −0.28 | 1.00 | −4.20 to 3.65 |
| Ankle ROM | 26.94 ± 9.82 | 25.69 ± 7.11 | 26.00± 6.73 | 26.12 ± 5.19 | −1.25 | 1.00 | 4.38 to 1.89 | 0.31 | 1.00 | −2.83 to 3.44 | 0.12 | 1.00 | −3.02 to 3.25 |
| Ankle angle at IC | 2.31 ± 6.64 | 1.85 ± 6.81 | 2.55 ± 5.63 | 2.65 ± 7.34 | −0.46 | 1.00 | −1.91 to 0.98 | 0.70 | 1.00 | −0.74 to 2.15 | 0.10 | 1.00 | −1.35 to 1.54 |
| Peak ankle plantar flexion toe-off (º) | −3.14 ± 12.26 | −2.05 ± 9.84 | −3.03 ± 8.61 | −3.30 ± 9.61 | 1.10 | 1.00 | −1.41 to 3.60 | −0.98 | 1.00 | −3.49 to 1.52 | −0.27 | 1.00 | −2.77 to 2.23 |
ROM, range of motion; º, grade; IC, initial contact. * p < 0.05 using ANOVA of repeated measures (post hoc Bonferroni Adjustment). SD, standard deviation. Baseline measurement is before the first intervention period A, the second measurement is after the first intervention period A and before the intervention period B, the third measurement is after the intervention period B and before the second intervention period A, and the fourth measurement is after the second intervention period A.